Case Study
Diane Denny, DBA, MHA, FACHE, CPHQ, CPPS; Brandon Bosch, MPH; Morgan Hannaford, MA; Scott R Hartman, MS, PMP
J Clin Pathways. 2019;5(3):39-47. doi:10.25270/jcp.2019.04.00069
Received December 13, 2018; accepted March 13, 2019.
Columns
CME Corner
C Ola Landgren, MD, PhD
J Clin Pathways. 2019;5(3):13-14. doi:10.25270/jcp.2019.04.00070
Pathways in Practice
ER+, HER2- Breast Cancer Pathways at University of Chicago Hospital and OHSU Knight Cancer Institute
JCP Editors
J Clin Pathways. 2019;5(3):9-11.
Editorial
Nicolas Ferreyros, Director of Communications, Community Oncology Alliance
J Clin Pathways. 2019;5(3):8.
Business of Pathways
Michael Willis, PhD; Cheryl Neslusan, PhD; Silas Martin, MS; Pierre Johansen, MSc; Christian Asseburg, PhD; Duncan O’Brien, BEc; Ira Klein, MD, MBA, FACP—Column Editor
J Clin Pathways. 2019;5(3):26-29. doi:10.25270/jcp.2019.04.00074
Pharma Insights
Larry Blandford, PharmD—Column Editor
J Clin Pathways. 2019;5(3):22-24. doi:10.25270/jcp.2019.04.00073
Tools for Transformation
Gordon Kuntz—Column Editor
J Clin Pathways. 2019;5(3):19-21. doi:10.25270/jcp.2019.04.00072
Departments
Editor's Page
Winston Wong, PharmD, Editor-in-Chief
J Clin Pathways. 2019;5(3):3.
Features
Case Study
Diane Denny, DBA, MHA, FACHE, CPHQ, CPPS; Brandon Bosch, MPH; Morgan Hannaford, MA; Scott R Hartman, MS, PMP
J Clin Pathways. 2019;5(3):39-47. doi:10.25270/jcp.2019.04.00069
Received December 13, 2018; accepted March 13, 2019.
Research Report
Mihaela C Munteanu, EdD, MS; John M Burke, MD
J Clin Pathways. 2019;5(3):31-38,S1-S3. doi: 10.25270/jcp.2019.04.00068
Received February 7, 2019; accepted March 25, 2019.